Glucose/prednisoneLack of efficacy and treatment non-compliance

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2008卷 / 1期

关键词：

D O I：

10.1007/s40278-024-59062-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：168 / 168

相关论文

共 50 条

[21] Non-compliance with tuberculosis treatment: The Kumasi experience
Twumasi, PA
TROPICAL DOCTOR, 1996, 26 (01) : 43 - 44
[22] Multiple drugsVarious toxicities and treatment non-compliance
Reactions Weekly, 2024, 2003 (1) : 631 - 631
[23] OlanzapineRhabdomyolysis and treatment non-compliance: case report
Reactions Weekly, 2022, 1935 (1) : 349 - 349
[24] Incidence of and factors for non-compliance to antituberculous treatment
Caceres, Flor de Maria
Orozco, Luis Carlos
BIOMEDICA, 2007, 27 (04): : 498 - 504
[25] Adalimumab/infliximabOral tuberculosis and treatment non-compliance
Reactions Weekly, 2024, 2016 (1) : 19 - 19
[26] ALCOHOLISM AND NON-COMPLIANCE WITH MEDICAL-TREATMENT
NIMS, RG
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1979, 3 (02) : 188 - 188
[27] Multiple drugsLack of efficacy, treatment non-compliance and intentional drug misuse: case report
Reactions Weekly, 2024, 2025 (1) : 301 - 301
[28] Multiple drugsVarious toxicities, lack of efficacy, treatment non-compliance and drug exposure in pregnancy
Reactions Weekly, 2024, 1998 (1) : 362 - 362
[29] PazopanibVarious toxicities, intentional misuse, treatment non-compliance and lack of efficacy: case report
Reactions Weekly, 2025, 2051 (1) : 258 - 258
[30] Larotrectinib/octreotideWithdrawal pain syndrome, treatment non-compliance and lack of efficacy: case report
Reactions Weekly, 2025, 2049 (1) : 196 - 196

← 1 2 3 4 5 →